Dr. Stephen (Steven) Klein
speaker
467 appearances
1 recordings
1 series
first heard Jul 2026
last heard 2 Jul
Dr. Stephen (Steven) Klein’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.
Appearances
We talked about it last episode, as well as buprenorphine, something called Welbutrin.
There's one paper that shows that that's quite effective.
And for cocaine use disorder, it's also a lot of off-label prescribing.
But there's nothing illegal, unethical.
anything about off-label prescribing.
It's just a doctor's analysis of the data and then a very careful risk-benefit calculus of this if it can help the patient in front of them.
Largely, yes.
And what's hard about the way that our insurance system is currently set up is someone like me who's meeting a patient for a 28-day residential treatment stay, it's almost impossible for me to even prescribe them for FDA-approved indications.
So currently, if you want to be prescribed a GLP-1 for weight loss, many insurances will deny until you can prove three to six months of failed weight loss on diet and exercise.
Okay.
I don't have that data as someone who's meeting a patient for the first time and taking care of them for 28 to 30 days.
It's become a way that insurance companies can deny access to these medications because they're very expensive and because so many Americans are overweight.
So many people qualify who can't even get them for the FDA approved indications.
Sure.
It's definitely a possibility.
Insurance company could approve for a patient under my care if their BMI was 35.
They may approve Ozempic, more likely Wago, V or Zep bound for that patient.
And they may deny it for a patient whose BMI is under 30.
There is kind of a feared reporting of this, that people become anhedonic or really lose interest in all things.
I don't see it.
Showing 281–300 of 467 · page 15 of 24
← Previous
Next →